Literature DB >> 15308738

Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b.

John Bernet1, Jayati Mullick, Yogesh Panse, Pradeep B Parab, Arvind Sahu.   

Abstract

The vaccinia virus complement control protein (VCP) is an immune evasion protein of vaccinia virus. Previously, VCP has been shown to bind and support inactivation of host complement proteins C3b and C4b and to protect the vaccinia virions from antibody-dependent complement-enhanced neutralization. However, the molecular mechanisms involved in the interaction of VCP with its target proteins C3b and C4b have not yet been elucidated. We have utilized surface plasmon resonance technology to study the interaction of VCP with C3b and C4b. We measured the kinetics of binding of the viral protein to its target proteins and compared it with human complement regulators factor H and sCR1, assessed the influence of immobilization of ligand on the binding kinetics, examined the effect of ionic contacts on these interactions, and sublocalized the binding site on C3b and C4b. Our results indicate that (i) the orientation of the ligand is important for accurate determination of the binding constants, as well as the mechanism of binding; (ii) in contrast to factor H and sCR1, the binding of VCP to C3b and C4b follows a simple 1:1 binding model and does not involve multiple-site interactions as predicted earlier; (iii) VCP has a 4.6-fold higher affinity for C4b than that for C3b, which is also reflected in its factor I cofactor activity; (iv) ionic interactions are important for VCP-C3b and VCP-C4b complex formation; (v) VCP does not bind simultaneously to C3b and C4b; and (vi) the binding site of VCP on C3b and C4b is located in the C3dg and C4c regions, respectively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308738      PMCID: PMC506936          DOI: 10.1128/JVI.78.17.9446-9457.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Microbial subversion of the immune response.

Authors:  P J Lachmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-19       Impact factor: 11.205

Review 2.  Poxvirus immunomodulatory strategies: current perspectives.

Authors:  J B Johnston; Grant McFadden
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

Review 3.  Role of complement in the control of HIV dynamics and pathogenesis.

Authors:  Heribert Stoiber; Cornelia Speth; Manfred P Dierich
Journal:  Vaccine       Date:  2003-06-01       Impact factor: 3.641

Review 4.  Poxviruses and immune evasion.

Authors:  Bruce T Seet; J B Johnston; Craig R Brunetti; John W Barrett; Helen Everett; Cheryl Cameron; Joanna Sypula; Steven H Nazarian; Alexandra Lucas; Grant McFadden
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

5.  Mapping of regions within the vaccinia virus complement control protein involved in dose-dependent binding to key complement components and heparin using surface plasmon resonance.

Authors:  Scott A Smith; R Sreenivasan; Gunasekaran Krishnasamy; Ken W Judge; Krishna H Murthy; Shrihari J Arjunwadkar; David R Pugh; Girish J Kotwal
Journal:  Biochim Biophys Acta       Date:  2003-08-21

Review 6.  Herpes and pox viral complement control proteins: 'the mask of self'.

Authors:  Jayati Mullick; Archana Kadam; Arvind Sahu
Journal:  Trends Immunol       Date:  2003-09       Impact factor: 16.687

7.  'Complementing' viral infection: mechanisms for evading innate immunity.

Authors:  Sun-Hwa Lee; Jae U Jung; Robert E Means
Journal:  Trends Microbiol       Date:  2003-10       Impact factor: 17.079

Review 8.  Kaposi's sarcoma associated herpesvirus immune evasion strategies.

Authors:  Robert E Means; Sabine M Lang; Young-Hwa Chung; Jae U Jung
Journal:  Front Biosci       Date:  2002-05-01

9.  The C4A and C4B isotypic forms of human complement fragment C4b have the same intrinsic affinity for complement receptor 1 (CR1/CD35).

Authors:  Liliana Clemenza; David E Isenman
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

Review 10.  Viral mimicry of the complement system.

Authors:  John Bernet; Jayati Mullick; Akhilesh K Singh; Arvind Sahu
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

View more
  19 in total

1.  Identification of complement regulatory domains in vaccinia virus complement control protein.

Authors:  Jayati Mullick; John Bernet; Yogesh Panse; Sharanabasava Hallihosur; Akhilesh K Singh; Arvind Sahu
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 2.  The vaccinia virus A56 protein: a multifunctional transmembrane glycoprotein that anchors two secreted viral proteins.

Authors:  Brian C DeHaven; Kushol Gupta; Stuart N Isaacs
Journal:  J Gen Virol       Date:  2011-06-29       Impact factor: 3.891

3.  Identification of functional domains in kaposica, the complement control protein homolog of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8).

Authors:  Jayati Mullick; Akhilesh K Singh; Yogesh Panse; Vivekanand Yadav; John Bernet; Arvind Sahu
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.

Authors:  Jitendra Kumar; Viveka Nand Yadav; Swastik Phulera; Ashish Kamble; Avneesh Kumar Gautam; Hemendra Singh Panwar; Arvind Sahu
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

5.  Cell surface expression of the vaccinia virus complement control protein is mediated by interaction with the viral A56 protein and protects infected cells from complement attack.

Authors:  Natasha M Girgis; Brian C Dehaven; Xin Fan; Kendra M Viner; Mohammad Shamim; Stuart N Isaacs
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

6.  Dissection of functional sites in herpesvirus saimiri complement control protein homolog.

Authors:  Malik Johid Reza; Ashish Kamble; Muzammil Ahmad; Musti V Krishnasastry; Arvind Sahu
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

7.  The paramyxoviruses simian virus 5 and mumps virus recruit host cell CD46 to evade complement-mediated neutralization.

Authors:  John B Johnson; Ken Grant; Griffith D Parks
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

8.  Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation.

Authors:  Viveka Nand Yadav; Kalyani Pyaram; Jayati Mullick; Arvind Sahu
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

Review 9.  Monkeypox virus and insights into its immunomodulatory proteins.

Authors:  Jessica R Weaver; Stuart N Isaacs
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

10.  Solution Structures of Complement C2 and Its C4 Complexes Propose Pathway-specific Mechanisms for Control and Activation of the Complement Proconvertases.

Authors:  Sofia Mortensen; Jan K Jensen; Gregers R Andersen
Journal:  J Biol Chem       Date:  2016-06-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.